How to Buy Cytek Biosciences Stock
Cytek Biosciences Inc
Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
Cytek Biosciences stock last closed at $3.65, down 0.54% from the previous day, and has decreased 38.34% in one year. It has underperformed other stocks in the Medical Devices industry by 0.2 percentage points. Cytek Biosciences stock is currently +11.62% from its 52-week low of $3.27, and -52.16% from its 52-week high of $7.63.
At the moment, there are 128.1M CTKB shares outstanding. The market capitalization of CTKB is $467.56M. In the last 24 hours, 424,927 CTKB shares were traded.
How to Buy Cytek Biosciences Stock
Not sure how to invest in Cytek Biosciences stock? Here's how.
- Choose where to buy Cytek Biosciences stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Cytek Biosciences stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Pick your method of payment and add your information.
- Research Cytek Biosciences stock: The Cytek Biosciences ticker symbol is CTKB. Is Cytek Biosciences stock a good investment? Should you buy shares of CTKB? How do CTKB's underlying business fundamentals look? Do top analysts think Cytek Biosciences is a good buy? Why has CTKB's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if CTKB is a good stock to buy).
- Make your CTKB purchase: Decide if you will purchase CTKB shares at the current market price or use a limit order to purchase CTKB stock at a given price.
- Get the latest scoop on your investment in CTKB: Create a watchlist to key updates about your new investment in Cytek Biosciences shares.
Step 1: Choose where to buy Cytek Biosciences stock
You will need an online brokerage account in order to access the NASDAQ market and buy CTKB shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal info so you can invest in CTKB stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on the best investment app, your next step is to transfer the money for your investment:
Check out the walkthrough below to see the process of transferring funds into your new investment account.
Step 4: Research Cytek Biosciences stock
After you have selected the best place to buy Cytek Biosciences stock, it's very important to evaluate their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
Cytek Biosciences Metrics
CTKB Due Diligence Checks
WallStreetZen was designed to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on CTKB's stock page.
Is CTKB stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge CTKB's intrinsic value.
Using relative valuations ratios:
- CTKB could be undervalued based on its P/B ratio of 1.18x, relative to Medical Devices industry P/B ratio of 3.8x
You can access more valuation research on CTKB's stock here.
CTKB Financials at a glance
Positive Health Checks:
- CTKB's operating cash flow of $25.38M allows it to safely service it's debt of $8.60M.
- CTKB has a low debt to equity ratio of 0.26.
- CTKB profit margin has gone up from -6.3% to -3% in the past year.
- Total CTKB debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the CTKB balance sheet.
- There are more short-term assets than long-term liabilities on the CTKB balance sheet.
Negative Health Checks:
- CTKB earnings of -$461.00k is not enough to cover its interest payments.
Is Cytek Biosciences stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 Equities analysts who give ratings on CTKB, the consensus analyst rating on CTKB is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Cytek Biosciences stock forecast page.
CTKB Trading Indicators
Is CTKB Making Money?
Last year, CTKB revenue was $200.45M. Over the last 5 year, CTKB's revenue has gone up by 28.2% per year. This was faster than the Medical Devices industry average of 9.92%.
You can research CTKB's earnings and revenue performance here.
Are CTKB insiders buying or selling the stock?
In the last year, executives and large shareholders at CTKB have sold more shares than they have bought.
Valerie Barnett, CHIEF LEGAL OFFICER of CTKB, was the latest CTKB insider to sell. They sold $8,336.32 worth of CTKB shares on Mar 10, 2025.
Get more info about who owns CTKB shares here.
Can I get consistent income from CTKB stock?
No, Cytek Biosciences doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CTKB purchase
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, use a limit order.
Press the Open Trade button and eToro will place the order.
If you need more info about buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your investment in CTKB
Now that you own some CTKB shares, you'll want to keep up with your new company.
Add CTKB to a watchlist to get the latest updates about your CTKB stock.
CTKB Feed
How to Buy Stock in Cytek Biosciences
To reiterate, here are the 6 steps for buying Cytek Biosciences stock:
- Choose where to buy Cytek Biosciences stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Research Cytek Biosciences stock
- Make your CTKB purchase
- Get the latest scoop on your investment in CTKB
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Cytek Biosciences, create your watchlist below.
Other "How To" Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.